Severe coagulopathy Specific genetic Specific genetic lesion lesion Response to differentiating agents (RA, ATO) agents (RA, ATO) Striking sensitivity.
Advanced & Metastatic Gastric Cancer
CAELYX CLINICAL TRIALS Metastatic Breast Cancer (MBC)
1 Abraxane ® (paclitaxel protein-bound particles for injectable suspension). Each 50 mL vial contains 100 mg of paclitaxel and 900 mg of human albumin.
Overview of Targeted Therapies for Esophageal and Gastric Cancers Johanna Bendell, MD Director, GI Oncology Research Associate Director, Drug Development.
Novel Biologic Therapies for Second-Line Gastric Cancer
Interest in Topics Related to the Treatment of Patients with CLL (Percent Responding 9 or 10)
Novel Biologic Therapies for Second-Line Gastric Cancer Charles S. Fuchs, MD Dana-Farber Cancer Institute Harvard Medical School Boston, MA.